Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Haihong Hu, Taolan Zhang, Yiwen Wu, Meina Deng, Huiling Deng & Xiaoyan Yang. (2022) Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 16:8, pages 753-765.
Read now
Read now
Yan Du, Di Liu & Yongzhong Du. (2022) Recent advances in hepatocellular carcinoma therapeutic strategies and imaging-guided treatment. Journal of Drug Targeting 30:3, pages 287-301.
Read now
Read now
Vikas Kumar, Mahfoozur Rahman, Prashant Gahtori, Fahad Al-Abbasi, Firoz Anwar & Hyung Sik Kim. (2021) Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine. Expert Opinion on Drug Delivery 18:6, pages 673-694.
Read now
Read now
Jiongxi Lei, Shuangchen Cong, Maoyuan Song, Wenxi Zhang, Guanghua Peng, Xinru Li & Yan Liu. (2018) Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy. Drug Development and Industrial Pharmacy 44:4, pages 570-581.
Read now
Read now
Thangirala Sudha, Dhruba J Bharali, Murat Yalcin, Noureldien HE Darwish, Melis Debreli Coskun, Kelly A Keating, Hung-Yun Lin, Paul J Davis & Shaker A Mousa. (2017) Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac. International Journal of Nanomedicine 12, pages 1305-1315.
Read now
Read now
Zhuanglei Gao, Zhaoxia Li, Jieke Yan & Peilin Wang. (2017) Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy. Drug Design, Development and Therapy 11, pages 2595-2604.
Read now
Read now
Articles from other publishers (24)
Lucia Gutierrez-Romero, Paula Díez & Maria Montes-Bayón. (2024) Bioanalytical strategies to evaluate cisplatin nanodelivery systems: From synthesis to incorporation in individual cells and biological response. Journal of Pharmaceutical and Biomedical Analysis 237, pages 115760.
Crossref
Crossref
Yu Chen, Fukuan Du, Liyao Tang, Jinrun Xu, Yueshui Zhao, Xu Wu, Mingxing Li, Jing Shen, Qinglian Wen, Chi Hin Cho & Zhangang Xiao. (2022) Carboranes as unique pharmacophores in antitumor medicinal chemistry. Molecular Therapy - Oncolytics 24, pages 400-416.
Crossref
Crossref
Yang Guang. (2022) Ligand-modified Nanomaterials for Specific Targeting of Hepatocellular Carcinoma. Journal of Modern Nanotechnology 2:1.
Crossref
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Crossref
Laís E. Scheeren, Daniele R. Nogueira-Librelotto, Daniela Mathes, Micheli M. Pillat, Letícia B. Macedo, Montserrat Mitjans, M. Pilar Vinardell & Clarice M.B. Rolim. (2021) Multifunctional PLGA nanoparticles combining transferrin-targetability and pH-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells. Toxicology in Vitro 75, pages 105192.
Crossref
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Crossref
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli, Md. Waris & Tanuja Singh. (2021) Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting. Current Drug Targets 22:7, pages 779-792.
Crossref
Crossref
Theeraphong Pho-iam, Primana Punnakitikashem, Chayapol Somboonyosdech, Sirinapa Sripinitchai, Patarabutr Masaratana, Vorapan Sirivatanauksorn, Yongyut Sirivatanauksorn, Chamaiphorn Wongwan, Kytai T. Nguyen & Chatchawan Srisawat. (2021) PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line. Biochemical and Biophysical Research Communications 553, pages 191-197.
Crossref
Crossref
Jian Zhang, Xiuxiu Wang, Liang Cheng, Jiandong Yuan & Zhiyuan Zhong. (2021) SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo. Colloids and Surfaces B: Biointerfaces 197, pages 111399.
Crossref
Crossref
Mahmoud A. Younis, Ikramy A. Khalil & Hideyoshi Harashima. (2020) Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications. Advanced Therapeutics 3:11, pages 2000087.
Crossref
Crossref
Seyedeh Sara Esnaashari, Samad Muhammadnejad, Saeid Amanpour & Amir Amani. (2020) A Combinational Approach Towards Treatment of Breast Cancer: an Analysis of Noscapine-Loaded Polymeric Nanoparticles and Doxorubicin. AAPS PharmSciTech 21:5.
Crossref
Crossref
Danuta Kuzajewska, Agata Wszołek, Wojciech Żwierełło, Lucyna Kirczuk & Agnieszka Maruszewska. (2020) Magnetotactic Bacteria and Magnetosomes as Smart Drug Delivery Systems: A New Weapon on the Battlefield with Cancer?. Biology 9:5, pages 102.
Crossref
Crossref
Xiaoqin Chi, Kun Liu, Xiangjie Luo, Zhenyu Yin, Hongyu Lin & Jinhao Gao. (2020) Recent advances of nanomedicines for liver cancer therapy. Journal of Materials Chemistry B 8:17, pages 3747-3771.
Crossref
Crossref
Laís E. Scheeren, Daniele R. Nogueira-Librelotto, Letícia B. Macedo, Josiele M. de Vargas, Montserrat Mitjans, M. Pilar Vinardell & Clarice M. B. Rolim. (2020) Transferrin-conjugated doxorubicin-loaded PLGA nanoparticles with pH-responsive behavior: a synergistic approach for cancer therapy. Journal of Nanoparticle Research 22:3.
Crossref
Crossref
Lorena Baboci, Sara Capolla, Federica Di Cintio, Federico Colombo, Prisca Mauro, Michele Dal Bo, Monica Argenziano, Roberta Cavalli, Giuseppe Toffoli & Paolo Macor. (2020) The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target. Journal of Oncology 2020, pages 1-15.
Crossref
Crossref
Zhe Ma, Bing Zhang, Yuqi Fan, Meng Wang, Dereje Kebebe, Jiawei Li & Zhidong Liu. (2019) Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomedicine & Pharmacotherapy 117, pages 109128.
Crossref
Crossref
Likun Hu, Ting Zhang, Dong Liu, Guiwen Guan, Jian Huang, Peter Proksch, Xiangmei Chen & Wenhan Lin. (2019)
Notoamide-type alkaloid induced apoptosis and autophagy
via
a P38/JNK signaling pathway in hepatocellular carcinoma cells
. RSC Advances 9:34, pages 19855-19868.
Crossref
Crossref
Mariana Magalhães, Ana Figueiras & Francisco Veiga. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers
257
291
.
Cristian Turato, Anna Balasso, Vinicio Carloni, Claudio Tiribelli, Francesca Mastrotto, Antonio Mazzocca & Patrizia Pontisso. (2017) New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma. Journal of Controlled Release 268, pages 184-197.
Crossref
Crossref
Rinku Dutta & Ram I. Mahato. (2017) Recent advances in hepatocellular carcinoma therapy. Pharmacology & Therapeutics 173, pages 106-117.
Crossref
Crossref
Nourhan K. Mohamed, Mostafa A. Hamad, Mohamed Z.E. Hafez, Karen L. Wooley & Mahmoud Elsabahy. (2017) Nanomedicine in management of hepatocellular carcinoma: Challenges and opportunities. International Journal of Cancer 140:7, pages 1475-1484.
Crossref
Crossref
Baomin Zhu, Huanying Zhang & Lianling Yu. (2017) Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation. Biomedicine & Pharmacotherapy 86, pages 547-554.
Crossref
Crossref
Dazhong Chen, Fangyuan Xie, Duxin Sun, Chuan Yin, Jie Gao & Yanqiang Zhong. (2017) Nanomedicine-Mediated Combination Drug Therapy in Tumor. Open Pharmaceutical Sciences Journal 4:1, pages 1-10.
Crossref
Crossref
Ju Yeon Choi, Raj Kumar Thapa, Chul Soon Yong & Jong Oh Kim. (2016) Nanoparticle-based combination drug delivery systems for synergistic cancer treatment. Journal of Pharmaceutical Investigation 46:4, pages 325-339.
Crossref
Crossref